Pilot study of lenalidomide-rituximab combination in relapsed/refractory diffuse large b cell lymphoma

Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: 1f3ab0a59e7aec0a2f7439b04166237d6433368e
First added on: Feb 05, 2025